Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Kaival Brands Innovations Group Announces Reverse Stock Split
-
Security Journey Study Reveals Only 20 percent of Organizations Can Confidently Detect a Software Vulnerability Before an Application is Released
-
MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs
-
Form 8.3 - Young & Co's Brewery plc
-
The Canadian National Emergency Preparedness and Climate Adaptation Convention to Take Place September 24-26, 2024 in Ottawa
-
Old National's 4th Quarter and Record Full-Year Results Supported by Strong Deposit Franchise, Stable Credit Quality and Well-Managed Expenses
-
Ethical Web AI Launches AI Seek 6.0
-
Solid Power Announces $50 Million Share Repurchase Authorization
-
Old National's 4th Quarter and Record Full-Year Results Supported by Strong Deposit Franchise, Stable Credit Quality and Well-Managed Expenses
-
Duos RIP® Scans Over Eight and a Half Million Railcars in ‘23
-
Economic pessimism significantly outpaces optimism among top Canadian business leaders: CPA Canada survey
-
Rumble Announces Public Launch of Rumble Studio
-
Phase 1 Clinical Data for SYS6002 (CRB-701) to be presented at 2024 ASCO GU
-
NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)
-
InfiniBox™ SSA II Named Storage Product of the Year 2023 in the Disk and Disk Subsystems Category by TechTarget
-
MedBright AI’s MedMatrix to Expand Its AI Offerings for Cosmetic Marketing & Clinical Trial Analytics
-
Cerence to Announce Fiscal First Quarter Results on February 6, 2024
-
MKS Instruments Announces Fourth Quarter and Full Year 2023 Earnings Conference Call
-
Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ON
-
Rumble Announces Public Launch of Rumble Studio
-
Lenders One Welcomes 29 New Member Companies to the Cooperative
-
VCI Global Secures Its First IPO Consultancy Deal in 2024 With a Singapore-Based Fin-MedTech Medical Group
-
Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts
-
PetVivo Recieves Notice of Allowance from United States Patent and Trademark Office for Key Patent Application
-
Pulse Oil Announces Closing of Rights Offering
-
Scandinavian Digital Expands Partnership With Tacton to Resell Tacton CPQ Across the Nordics and DACH Regions
-
Genasys Inc. Schedules Fiscal First Quarter 2024 Financial Results and Conference Call for February 13, 2024
-
Enphase Energy Announces Conference Call to Review Fourth Quarter and Full Year 2023 Financial Results Tuesday, Feb. 6, 2024 at 4:30 p.m. Eastern Time
-
InnovAge to Announce Fiscal Second Quarter 2024 Financial Results and Host Conference Call Tuesday, February 6, 2024
-
NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)
-
Nasdaq Capital Access Platforms Launches Leading Indicator for IPO Activity
-
Bionano Announces Full Commercial Release of the Stratys™ System for High Throughput Optical Genome Mapping
-
Red Cat Integrates Advanced AI Capabilities into Next-Generation Drone System for the U.S. Army’s Short Range Reconnaissance Program
-
4DMT Receives Rare Pediatric Disease Designation from FDA for Aerosolized 4D-710 for Treatment of Cystic Fibrosis Lung Disease
-
Fobi AI Signs $440,000 License Renewal with Leading Global Insurance Provider To Deliver Digital Proof Of Insurance For Europe
-
Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million
-
New Survey Reveals Key to Employee Happiness in 2024
-
Park Place Technologies Completes Purchase of NorthSmart Third Party Maintenance Services
-
Recce Pharmaceuticals Reports Positive Phase I/II Trial Results of RECCE® 327 for the Treatment of Diabetic Foot Infections
-
Marketers Given Marginal Grades for ABM-Driven Revenue Growth
-
Rezolute Receives Innovation Passport Designation from the U.K. Innovative Licensing and Access Pathway Steering Group for RZ358 in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
-
Resilinc Recognized in the 2023 Gartner® Market Guide for Supplier Risk Management Solutions
-
Intapp to announce fiscal second quarter 2024 financial results on February 6, 2024
-
Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts
-
Alliance Trust PLC - Net Asset Value
-
Offentliggørelse af vedtægter, Investeringsforeningen Wealth Invest
-
Clubhouse Media Group, Inc. Announces Model Bre Young Joins HoneyDrip.com
-
Lantheus Announces CEO Succession Plan
-
IAOMT Position Paper Examines the Science of Jawbone Cavitations Just Ahead of the Yankee Dental Congress!
-
The Board of Directors of Siili Solutions Plc resolved on a new performance period for the Performance Share Plan 2023–2027
